Claudia Vener

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Patient Reported

Structural Basis

Top Venues

Antibiotics (Basel, Switzerland)

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Ilaria Cutica, Silvia Riva, Ester Maria Orlandi, Alessandra Iurlo, Claudia Vener, Chiara Elena, Cristina Bucelli, Daniele Cattaneo, Elisa Tomezzoli, Gabriella Pravettoni
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients. Patient preference and adherence 16 (2022)
Daniele Cattaneo, Claudia Vener, Elena Maria Elli, Cristina Bucelli, Nicole Galli, Fabrizio Cavalca, Giuseppe Auteri, Donatella Vincelli, Bruno Martino, Umberto Gianelli, Francesca Palandri, Alessandra Iurlo
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis. Cancers 14 (7) (2022)
Carlo Pietrasanta, Andrea Ronchi, Claudia Vener, Chiara Poggi, Claudia Ballerini, Lea Testa, Rosaria Maria Colombo, Elena Spada, Carlo Dani, Fabio Mosca, Lorenza Pugni
Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial. Antibiotics (Basel, Switzerland) 10 (5) (2021)